Your browser doesn't support javascript.
loading
The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells.
Wang, Lei-Ping; Cao, Jun; Zhang, Jian; Wang, Bi-Yun; Hu, Xi-Chun; Shao, Zhi-Min; Wang, Zhong-Hua; Ou, Zhou-Luo.
Afiliación
  • Wang LP; Department of Medical Oncology, Fudan University Shanghai Cancer Center, 270 Dongan Road, Shanghai, China.
  • Cao J; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhang J; Department of Medical Oncology, Fudan University Shanghai Cancer Center, 270 Dongan Road, Shanghai, China.
  • Wang BY; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Hu XC; Department of Medical Oncology, Fudan University Shanghai Cancer Center, 270 Dongan Road, Shanghai, China.
  • Shao ZM; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Wang ZH; Department of Medical Oncology, Fudan University Shanghai Cancer Center, 270 Dongan Road, Shanghai, China.
  • Ou ZL; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Med Oncol ; 32(11): 254, 2015 Nov.
Article en En | MEDLINE | ID: mdl-26487662
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Quimiotaxis / Quimiocina CCL2 / Proteínas Quinasas p38 Activadas por Mitógenos / Receptores CCR Límite: Female / Humans Idioma: En Revista: Med Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Quimiotaxis / Quimiocina CCL2 / Proteínas Quinasas p38 Activadas por Mitógenos / Receptores CCR Límite: Female / Humans Idioma: En Revista: Med Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: China